Mobilization of fibrinolytic enzymes in synovial fluid and plasma of rheumatoid arthritis and spondyloarthropathy and their relation to radiological destruction

Journal of Rheumatology

Volumn 23, Issue 10, 1996, Pages 1704-1709

  Wållberg Jonsson, Solveig ^a   Rantapää Dahlqvist, Solbritt ^a   Nordmark, Lars ^a   Rånby, Mats ^b  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

fibrinolysis; plasma; radiological grading; rheumatoid arthritis; spondyloarthropathy; synovial fluid

Indexed keywords

AUROTHIOMALATE; AZATHIOPRINE; CORTICOSTEROID; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; PREDNISOLONE; PROUROKINASE; SALAZOSULFAPYRIDINE; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FIBRINOLYSIS; HUMAN; JOINT DESTRUCTION; MALE; PLASMA; PRIORITY JOURNAL; RADIOGRAPHY; RHEUMATOID ARTHRITIS; SPONDYLOARTHROPATHY; SYNOVIAL FLUID;

ADULT; AGED; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; KNEE JOINT; MALE; MIDDLE AGED; SPONDYLITIS, ANKYLOSING; SYNOVIAL FLUID; TISSUE PLASMINOGEN ACTIVATOR; URINARY PLASMINOGEN ACTIVATOR;

EID: 0029833351     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Mayer M: Biochemical and biological aspects of the plasminogen activation system. Clin Biochem 1990;23:197-211.
2. Mochan E, Keler T: Plasminogen degradation of cartilage proteoglycan. Biochem Biophys Acta 1984;800:312-5.
3. Werb Z, Mainardi CL, Vater CA, Harris ED: Endogenous activation of latent collagenase by rheumatoid synovial cells. N Engl J Med 1977;296:1017-23.
4. Okada Y, Harris ED, Nagase H: The precursor of a metallopeptidase from human rheumatoid synovial fibroblasts. Biochem J 1988;254:731-41.
5. Vincenti MP, Clark IM, Brinckerhoff CE: Using inhibitors of metalloproteinases to treat arthritis. Arthritis Rheum 1994;37:1115-26.
6. Bachmann F: Fibrinolysis. In: Verstraete M, Vermylen J, Lijnen R, Arnout J, eds. Thrombosis and Haemostasis 1987. Leuven: Leuven University Press, 1987:227:65.
7. Gaffney PJ: Breakdown products of fibrin and fibrinogen: Molecular mechanisms and clinical implications. J Clin Pathol 1980;(suppl)33:10-7.
8. Jasani MK: Fibrin: Metabolism, immunopathogenesis and significance in rheumatoid arthritis. In: Panayi GS, Johnson PM, eds. Immunopathogenesis of Rheumatoid Arthritis. Surrey: Reedbooks, 1978:137-46.
9. Barnhardt MI, Riddle MJ, Bluhm GB, Quintana C: Fibrin promotion and lysis in arthritic joints. Ann Rheum Dis 1967;26:206-18.
10. Bach Andersen R, Gormsen J: Fibrinolytic and fibrin stabilizing activity of synovial membranes. Ann Rheum Dis 1970;23:287-93.
11. van de Putte LBA, Noordhoek Hegt V, Overbeek TE: Activators and inhibitors of fibrinolysis in rheumatoid and nonrheumatoid synovial membranes. Arthritis Rheum 1977;20:671-8.
12. Matucci-Cerinic M, Lombardi A, Lotti T, et al.: Fibrinolytic activity in the synovial membrane of osteoarthritis. Br J Rheumatol 1990;29:249-53.
13. Weinberg JB, Pippen AMM, Greenberg CS: Extravascular fibrin formation and dissolution in synovial tissue of patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 1991;34:996-1005.
14. Brommer EJP, Dooijewaard G, Dijkmans BAC, Breedveld FC: Plasminogen activators in synovial fluid and plasma from patients with arthritis. Ann Rheum Dis 1992;51:965-8.
15. Kummer JA, Abbing JJ, de Boer J-P, et al.: Analysis of intraarticular fibrinolytic pathways in patients with inflammatory and noninflammatory joint diseases. Arthritis Rheum 1992;35:884-93.
16. Saxne T, Lecander I, Geborek P: Plasminogen activators and plasminogen activator inhibitors in synovial fluid. Difference between inflammatory joint disorders and osteoarthritis. J Rheumatol 1993;20:91-6.
17. Fearnley GR, Chacrabarti R, Evans JF: Fibrinolytic treatment of rheumatoid arthritis with phenformin plus ethyloestrenol. Lancet 1966;2:757-61.
18. Belch JJF, McArdle B, Madhok R, et al.: Decreased plasma fibrinolysis in patients with rheumatoid arthritis. Ann Rheum Dis 1984;43:114-7.
19. Kikuchi H, Tanaka S, Matsuo O: Plasminogen activator in synovial fluid from patients with rheumatoid arthritis. J Rheumatol 1987;14:439-45.
20. Kaarela K, Luukkainen R, Koskimies S: How often is seropositive rheumatoid arthritis an erosive disease? A 17-year followup study. J Rheumatol 1993;20:1670-3.
21. Isomäki H, Anttila P: Radiology of reactive arthritis. In: Toivanen A, Toivanen P, eds. Reactive Arthritis. Boca Raton, Florida: CRC Press, 1988:133-8.
22. Moll IMH: Seronegative arthropathies in the foot. In: Jayson MIV, Smidt LA, eds. Baillières Clinical Rheumatology: The Foot in Arthritis. London: Baillière Tindall, 1987;1:289-314.
23. Arnett FC, Edworthy SM, Bloch DA, et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
24. Dougados M, van der Linden S, Juhlin R: The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991;34:1218-27.
25. Rånby M, Sundell IB, Nilsson TK: Blood collection in strong acidic citrate anticoagulant used in a study of dietary influence on basal tPA activity. Thromb Haemost 1989;62:917-22.
26. Rånby M, Eriksson E, Tengborn L, Jonsson-Berg A-K, Risberg B: Fibrinolytic activity in blood characterized by well defined biochemical parameters; Pro-urokinase is released upon venous occlusion. In: Zilla P, Fasol R, Callow A, eds. Applied Cardiovascular Biology, 1989. Basel: Karger, 1990:124-30.
27. Rånby M, Bergsdorf N, Nilsson T, Mellbring G, Winblad B, Bucht G: Age dependence of tissue plasminogen activator concentrations in plasma, as studied by an improved enzyme-linked immunosorbent assay. Clin Chem 1986;32:2160-5.
28. Larsen A, Dale K, Eek M: Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn 1977;18:481-91.
29. Martel-Pelletier J, Faure M-P, McCollum R, Mineau F, Cloutier J-M, Pelletier J-P: Plasmin, plasminogen activators and inhibitor in human osteoarthritic cartilage. J Rheumatol 1991;18:1863-71.
30. Harris ED: Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med 1990;322:1277-89.
31. Butler M, Colombo C, Hickman L, et al.: A new model of osteoarthritis in rabbits. III. Evaluation of anti-osteoarthritic effects of selected drugs administered intraarticularly. Arthritis Rheum 1983;26:1380-6.
32. Jesperson J, Brommer EJP, Haverkate F, Nieuwenhuizen W: Degradation products of fibrin and fibrinogen in synovial fluid and in plasma of patients with rheumatoid arthritis. Fibrinolysis 1989;3:183-6.